Cardio Diagnostics Holdings Inc. (CDIO)
NASDAQ · Healthcare
Cardio Diagnostics Holdings Inc. annual/quarterly shareholder equity history from 2021 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Cardio Diagnostics Holdings Inc. shareholder equity for the quarter ending December 31, 2025 were 7.0M, a 27.04% decrease year-over-year.
- Cardio Diagnostics Holdings Inc. shareholder equity for 2025 were 7.0M, a 27.04% decrease from 2024.
- Cardio Diagnostics Holdings Inc. shareholder equity for 2024 were 9.6M, a 223.10% increase from 2023.
- Cardio Diagnostics Holdings Inc. shareholder equity for 2023 were 3.0M, a 31.23% decrease from 2022.
- Cardio Diagnostics Holdings Inc. shareholder equity for 2022 were 4.3M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Cardio Diagnostics Holdings Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $7 |
| 2024 | $10 |
| 2023 | $3 |
| 2022 | $4 |
| 2021 | $1 |
| Cardio Diagnostics Holdings Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $7 |
| 2024-12-31 | $10 |
| 2023-12-31 | $3 |
| 2022-12-31 | $4 |
| 2021-12-31 | $1 |
Cardio Diagnostics Holdings Inc. Shareholder Equity — FAQ
Cardio Diagnostics Holdings Inc. (CDIO) shareholder equity over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CDIO's shareholder equity history?
The chart and table above show Cardio Diagnostics Holdings Inc.'s shareholder equity by year and by quarter, including the growth rate.